Insider Transactions in Q2 2022 at Sierra Oncology, Inc. (SRRA)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 27
2022
|
Longitude Capital Partners Iii, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
16,030
+29.74%
|
-
|
|
Apr 27
2022
|
Longitude Capital Partners Iii, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
2,139,771
-100.0%
|
-
|
|
Apr 06
2022
|
William D. Turner Chief Reg & Tech Ops Officer |
SELL
Open market or private sale
|
Direct |
6,347
-100.0%
|
$234,839
$37.25 P/Share
|
|
Apr 06
2022
|
William D. Turner Chief Reg & Tech Ops Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,347
+50.0%
|
$76,164
$12.05 P/Share
|
|
Apr 05
2022
|
William D. Turner Chief Reg & Tech Ops Officer |
SELL
Open market or private sale
|
Direct |
100
-100.0%
|
$3,700
$37.09 P/Share
|
|
Apr 05
2022
|
William D. Turner Chief Reg & Tech Ops Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+50.0%
|
$1,200
$12.05 P/Share
|
|
Apr 04
2022
|
Mary Christina Thomson General Counsel |
SELL
Open market or private sale
|
Direct |
2,000
-100.0%
|
$70,000
$35.14 P/Share
|
|
Apr 04
2022
|
Mary Christina Thomson General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$26,000
$13.04 P/Share
|